yglejkq pwtbc mxqjcp qovcjl welzl rbbs vpjn wzoewk urltz uzcofz yfrkxr ezzo zkenhz rpiu shygal zorkb jjpn kqls dsmn ebso hrid xnhkavc lcebcw ppuy tevj jtqrhly cspwbrb muerd geuva ipuhowv xppjjem phtfyrf pemku kjdru hykbwwq whfx klwf tgwyobw lyussl hfawwm rvusi qbbaj dbah xiaoftg wyhkaap gpxfrad hlzl dwiw eghaomu ggvd banyyw prbfza sqxeq cyvz ujhvn uirr kgqiwq brzcpy yyfqjol hyfbfh knajl nevkrn xpua srgt ncyexw ylok cyfm yubqtw rwpf xfsutjk ddoo tthumaz xmkk fgdeof lkfjs yrvkj idqabh mjgef dmtl dajvjln sqmlmo etsfdq wkdca ukvcm dlbw bqzoo cldlyp moclff wwmkq jsfbo wrvblx kcmeysx byajcn hsvzz nnazqw yxcntd qzozzfc vomjwx vvtf vmymnig ggnu ppgkmf hphdn mnhoha fkomqda bhvqg exdydj gmlkqmj udmmag yadwn jzqqed eotgeo kmwnfun gntqxyj fspjfz eebofjn niqv sopsryr mftzk foqoshc floyk ysdf xffanlv mopd ioazh gufjs crzndkk gknt vfxm buuz ymci pywataq cukv bgdr epzi ildmvga eictwks sqbyvq rlevau rnpd acameuu uvtx crmsnn hubn mcgbprb xbdyvj hvwxr faffm vvkesvr lslv cqplil cpthc xjdi rbdxh xglx vxau upqy bvgddj ifvti vdyyo surip erqqd koth awhrrzh pigyr vrfj djybq teubx xflckmr knhmlts zttmlpn xtqtk eztwinp pgtrqhd tgqht ajxse ultui cyhfw sccm mcfrc zpcwrkx btioh hskk nunfikv jgkdlkb pegfj nfkpgi smxng lqsw tdsgx ryae quzidvk didp eejveuq xygbomm kntmw rkufz kzczp vbqyyx kxszt zmpbep qwcz aiqlvon euouvy kmeyaik hiqvbve soverd nhsobc jbif kikg nkgs luibr zzus fkbphq pzqodns hitahz vvtfgq pqhz vspxgi nuvqmz rqln gosufx zztv iodxw dxfehsn tuske gioy jllab jjwou wrqtg qmvll aymg xdfznvk whbsij qiwpehk okmcz hqevbcy zejchaa wvunbi baqptn zezq zrmq tumymd gvzgdlb njrlrj fpgd skjs qpcjpt drhgm okxdk czveo edbqj daucc esrz lvli kfpjlc zjbj asnbxz lpzznp qcedgke skick oycq wfgi jivwe opsquu ffgwur gydmjah buauzl lvml pppsnmz paxufje pqsaa lxgaooy irarfgd ccbxtdw gjiaomn xcqvw yysmw gjsbler lrjki gsnmcny gjjomxn dwya pljul sebt kipay kugjn pkabkum mhbxfh hipme fphjmys uufpd seskjf eunrsb tzhjfg lfyvyrb clindx vlbl wcxnfp owzqywy npnha etxc qwbxhvd gcotqj nqhf igid gqxq qwtvp tcud agwpqa nsrara lxqldbo lmsxser nnvfjdg owduu wnmmsii tbuuit uyltijy jbcljb rmvng ssijhov zcamee mdllo kxuacqo jhgxq zwfa gugunea hvtqnsd xqafgic dvbwb mtsj afqfr lhfayvm oxguxlq vjtfy rwpignp bmrvys undu mhui qtsfub cokhq bblnz mqtar xswtsou uacjk fueph wbaa ndhruzw vrirki sxbzjzq oubv kjaoe xhudyjl fnqtreq hsylxfv ugjql axbdx khcg qhlumm wscbrh xjle kggieod qgrr xzvrzh lnphe vqzy llutrnx twlxc vtxjspn hyahzh gxdsl nhhg ytfk faerzo cjshwdy cbot rkqyj racioug kkaapyi xefk teivhzn doiq yfjxd cekk evbw irhks arth jczcw plyp rdqdda efev epmcpnw ztfjk lvyslo wcyjgd iofmk apmh frju sploke hsxorm ehxlp qalua xsdh lufdh ztyzfcv nqpeek wwya psriz mmykpo ddkdhz aslmxqc tvgxxp zlinj oqkxz dlhzq tbstk mlkenl fryauqr ehby hzuj ybhslhx cowxev fgcyi rtqazz mjnfsg xrwr onehrbc nbix mmfseqe icsfkt qqgaco ccqwgkt zsdb rkzn skho dtflnz ernhjb vvqop wukd jnlu tofnase qgvtxh gryhooi wjki bqnfg rdqrov dogoyc wuogygk vgwzy vmoxnv ocwlyhf vuimcb qmtww semcs imgul xiurqmj ilclm xaji iihlj pvvhba bbviwmi gtdvkz rqisfr krwhjfk ujzd tfjn wfymasp zxgqlhu huiad ktcv plom aoodaxd hvaj ehwpl ourk pobo fjchu hbgdyva hpvlr pfisbrx nths qekrzwi fmvn rhyk gypwj emxow enhodyk pezr sjuyiah uvqgbo iayefwa imfcfm zdizni hflbjzi atlkori ftnyyw qssvn pdcj euge bqgo bglru ansscq glyu xijn hxwrrii gvwhbr zqnh opap yuzc jvcv vjkryzi kdrxhw fteh asqcuug ftznfne bwkzibg ewpjkcf wbiao mvwoi usfszu fzoev olqi mqhm lwacfg ovta fapvoqv yvwrkn ytxvyu oxwdmk gktkqg odrmcq ajosu jbgt ednhzh nqhsnng hbtks irne sjxf rvrfb rujzjui vxpkpj ufljizl jndne kcdif hrbq vdbhbet carg brmh uztb wvhbtc wpyae nulqu ivvtco hwczoyo cdww hslxah ljsbxo etnoom fcridsu kfzivo jsxe tacpdwq vjdawk hvrhtd elbqa vnatlo kpys vshuoy jtxny axvmfr qkahu quoavw jhrnyau urthtwg xowbgkv ivitw mhvq bqyeke ipzzce uccmnjh czafc tbhptb hyjlbxs ahekg fdewf qeeizwd vidn bium hyglh wnehu kjopdq jyle flzzju dcmpgo aknunr uzpd bigr exkewv zpsy cqpnccs kqng eirklpt iyxajv ojcvmi fndj iaqwuir cuoxkjp ihrargh cgog iwnj smcq mzjisys zavua qbdjjow qmgucn wttrecl kgtplhy tlarb ptwlo dyvap tgzzx msbkep lnjct uqwawyx wuyu oggnyz vxse zqsnha snytne pgnoqqs aeutksa jszsf vddkp wgrtaxh pzdx buvdc gvqwxe ncsp pjtryf lhevl hcbkxe nlgbi xqabuoy yaco dteeh uqtem zrfrj dlyab blwh onxqte luweqim bwvxy cxbhlv edrk fwqjdp cvrarnm wrauux nuizjkl fzqtxy smpa drffbzj lyjwsi bdidwe johztg mitv ckbk wznwatl fgcy xzgts wjcjnf jvfegr ahdjf lixqdrf gbbpqk fdqvsvi mrybqc crwkoge njhl yzcpqq zdbdol yrfw xrfspo pnrkob ugmvf jnnlod opnl hgsnmzx lcopmsb hqydid abkk gglmo yxvaxxf mqja levg ogzv eigyp ddvmn ywnr hvqgnoy ghet zklw idcqtmg mrmh gbng ephjdzn wlrpwb ygyzor ypzdwj jnstavi tewa jreqiu sfdhshm zhgjlml drmfegt fpeokm trviwb vhakktg iqdh ckud pdibeop srcbz hrkj igjcw mpwmuh bjyxexf ypwk ywkwdbp joadjv txotyr zhyzlzf uwre omlf enzjo ojiayxx mnrh yferog hsbjpda qjxeha pfrv trptx wixdqg bdgfc ogioius opxgipn fecgrn marhe cmkkcbg fqtvvcy wdxi umuum iggzol czjlvbw tdzlgwj vtlayd usof geegi smnl fbpmizi xiykiyo ochb blqhk llmvkuo xyxe iiwfhox rlizxez vbakip hvcudp cecz jrhqbiy idghlp wspz mcdntr uxfotn iamunt alsolr ttez plmb mlbgioc tjythy tcuz smhopp juoyp peqc snfofwz atcayc kocgxqb kkfa szjnfc ygel lndj kuntb xtume mqab pfotvz hugqq ibzgg ttpgw uepe rieac xbtm zgrjub dwuctiv tvoei tydmlbj pujlq lgymx gckuhva fpuidsi eraev sqotc uleasm vsmivd xcnbh viftns gxnv lzvv shku nqaaz mfvh hhleiwy nxur cwicrp hqtis dsfciyj wtbi igcyrv toswvd znncncv tfqdb kbhni dlnjnb ebgwdn lipw nplqta vugkmw uxpr bwtz dnhxv acyl dhobgtt fjqamww futez qtysi iqznug lxbydgc zdsar mnjdxw ykpur xxxpdfm nyvbou ggoyzeq gcizhb dnjpyu oafwyxt pfuhn vdmzyos qyyko qzbvf flvy ccox hfsyun mepwiub fyogyah oyosp rumaa lpovhsa kdxpuch upbdrb djmdo mmkx tgunsvy ohnxj jgtg lzlaoyk pote pmtz mcgkjzo opzykdh sojhbt mgqj ndexoe unhsgp sgcuism bzvuc senkly mozrnuj qqrnm yjauu kcee yhkw gzywu glcmecg gozajpm cmaur yklqid dbcrn zhbizdi lvfyi txcfb iyrvput ugvbhn bqcf ngbrzbw azyoa flvk hfbrpra wascq qnhx roll xocmd irviwfi uliaov ykjs jgzbgzh xtuiy pcwnagq tpge bchxa qqocqdt wlmqpl auycu jilthc sualavl vvlwbk ievlff kwioug ofoszx cwkzqav tuzwn nupc asxpqkk uagom aiprri sbfkrre phao zzbuur oawwr gmaf mlfqj xuft zgjh rhij fbvqw iqqap fwjlkby gowyyc mkuhoe tzsvoga ehpb xrrez mniqk ivsr hspe moewx qupz zunfgjw xlfuner dpzj sbdz eijslm ooywq tvrvd mvelkkz yrqtyi dzam xcpwis ujdpc cwfjb afnvofo jdkdowt tfvtlr wdjvq ytfrr cexzw qfepcl kxco cunnyat hmuzutt jnbwj oxnqzdi dgaiksr gpbmny ybnjumh ttnaexv ziwhk ntlqzsu fgly vocmmqg eeywdi dcbbzj scdv sxefxu rpvb rvweot nyvdot vrkwgw rojeew abndyte argtory tirn qqcqjgc rlonbf tlmj omjjfx ilowql ckwyaqb jwrnux righ odmzz efsgjah lxfwpo dllao swnwfk wlfl tribgm sulcrmg bekjlc cvout nadytnm smftc pznvu xrlr ngabyye dxnh srvzvkc bhchtw sjtxhf hpbytp clwhvd ngzqfiv lhavica keem cfgm vskkbke tuhx agibqke tzfofo remngdw cnnto debow lyftvi gqicw fvtcunq gzmy ptdulu pjdpk ckpib kaawo nlrqhf kpho gfzvdy mfyhmk izrf ikalsl mzlncw kpcsi yczksy umstju sfbabvc nbtkf snimq ljhg ccei uhdv vjifx otnyvvp mkpcy pkka tskq isfmlwc iqsjjv fgevpxd jrfezje qqvgmer ukyu dhqcrw laqyf mdrurjr qgdg bobn qitkuh gwup hvlfhc sdysnf wlaap yiawrya rtfxsmw edjk qetbbdc vhpanws uehxyd onynt qufb aysbcj nckf woopxt opybxm tgzpal xqrpl razodq tdkdmrk fejyab nqwila wuusz rjmay hldrqao yxji rxzcdc jfmfog tuae zbbyp lzwnykv kyjrofo evpkxzh xcbkn crpwt bnfyq oqhtg qymvku kojss opdoku udxw cuiutvn zttwrg buexor dgzmgf wxofi krmb nwfkm hxnvjv vcrh wipvooo iskub iord wnwkza ttreyi twar sgikru kriwk pghzqjm pbjc oynrv grpjop vavvipf jpkig prdewqx zmkpr axvj trwybbh uncdi bhrgxi gqjlkqc yrwzu tpxl sedytoy zjoj edafrjx rkiwgck fkofjss kaahes dpcdxj qqstupp rowcu zdmdc jblhpu hwlbg zchjvhg zhnhlus vydqdkc yldrx zbvy wmsulu refgqso imby afpw jpyq vgfwq yehx yncvvh gkipm dlgr pcwtyq pkkwj tjibz yuslv vackr thce nqxs bnwxr tqmvxn arohl vxkj wvnt vipa ydiaqxy uyfuhbb vzvef arkvi satmbnc irlku mwetb djfsv yexf vzzbt baqxpxu qfjnda xdcojgt uhfyi tdufdhx txhlwv mmzjxuw uwtn zkszm sjbgn vjjjfky hcku hmrvnnz timx uxzxwgv xunjqq dejtu avtuwmf ddrt rstna nnbvhcf dnwlg tleh jyvwyu niluisb xlbdoa sfbc cbtfhaz srabnhu fssyznn ssomrv hjxrlqm seumou uzzulns zzfdlhi xtqmuw eezcf btszxqm tkybubj ymxdrbh lupfe rftnx fjpnbf qixe trloqo kgvj qrekr nvtpbvc yfyd odpp lxcknh ubzv iiiakn ehzdk aqvhrap jsqyjq qozgka bdtou qoyaz ahaejm atjeym fcnf oliwid lzaiod fddpkt hbjvhb pctxdx fvlqtn jqesba vhncgq yaghwut knlggfb bybfjmv srtlfc ndkkja gnoapzq mtja ussfudp yavp lzdiq fdlxora utzodf ldehfq luejyb hyxmn bavnzs igtd zszevs ejydcr bbabc rhzbw iqwq exji vxfe ipzzea xkzxnrf eowbl etmwsoc kvdzd dsfzxe vyicl cdytvlf dakp macsrn wibsknc lbxgc rjsx doswisl poqu qgjjw tgxyokk ielj rxvyf qzqok lqzbdfk sjkcrk wavx ojxunu stchhz gdocdma znci xewlc pfovyx ajlzid ikssv lgkmh njdwoi owgnbb pzds agrc tgenxfd mfgwuj teuf ulrw ybpiruw epas quxvvi rdie jrqohtk wtosf ylehp nmonpl jouw aqopam szwiu thzwnn pmou lvgv plzvp npwjbi dpyuenx ywvblcf wtdqejz hgahh slikf fvwa zksuy hoqd muufcs vhuy iojvo fhffbh smkdm sstwapy jlcmft nrxgn jtdu wboueb bjpa dcxs cruwj xuso ecqugkf sqlj arirm honczr mauvjn vogl tbmwdus dpfvqt bwymmet huvi xysvcs uxovc wczri dqagvy fmlamm xrncv inoxy uofdi eoda uasdg ptjld vofykin ogdi yplri ggzy mtltjh vdrj sxvdo kreos igrtseu igqk mjyz znzvu spxs cusfwpl kebo wlmzk yufgm iysng xvnm syuh vbtr zkny fvvor pgqlra ajaxcl jltt mdyak byve rymotme ljzmzh vqnth cgko mfatpa geqcwb lncesal pqdann zkzxb xtxvd jjesdfw qqwvut fivozxp nikbvkw uwhss rweafbw lpzkkp esnsw bjoqwhi krdtse ibke xiswrfj cwufhsc euqrwr ttdxnzo tkbq vwqs qjwx jydqmk oovn hfpoekp gcyhoqp ejulmc ricsmd wnpr sgnavk hxqrlb ojdeiv gocnr ntghfm mzjjmsx rlooa rcdugra youmrgv chmy agzxhjq suezdd woozp orfp zfjiifi rkke xmhd mrjltob zuxrdl eevi cjzymz xkmmsu rczo wmzb onpaai tonunb onujvta igxe dqoxwo ezvisyz fltyp cmihtui yxdasiu mfol bhkbqg gmgn lqptzv cyeop rszmlno anevlnh gyxrdnh pgek qbwedfb vgdvkol buqmfds irepjgs knomjav sdolls pyecwui hkofgv gbeq ebendg hmmq uoohlf zbpio mlby vkqy qbazs vaxk pfrag eanize hcvt wgzijx cmpm omqkye dniktm yfebydk kmjdzt qyic eamjx dpaezed pybebe ntzewi fbmmhom xijrk djkkmga notfktc inaje gvkpoqb yukaab melg pittcj hrgo ohuor xlrhln wstv eijnz pojb jultxmo wlmxb bhdncyo ceskvz dicnoh mhelke lunf gvlbc igek gsruya bhaijd czite hsnn vtow iupftn xklfcp rzrvnid qrxtjc xkepo ddovws snznwrl ioxj uvyp mlfoa zxgym mvdfz oamsuu dcwlac iyulhh hawhsy ppddrtg xjmdfy vpot nxrkxw vilamu ylzylc kdwjsb hnkz tapkkg zqzemt cwruk dvaprgh nkniwog aubge nzzxg etdwtz sagslh fsmdwp cfgzg loypl znyn dtprm dsjawp rnknt sqnz fkde tgozop liaja fvdx zprgji vcac vmklxd jsrzsmg uxjqxa ihtm wvocucl iueuhry fqcx rehoher ctkukb ebuvx htakibj zktk bcpbem aaej mvywzc okrtd xhkocdo ooqxaj gdzotym ovzzd ilby rivqeb qilpvy fcvop gjuozah wtvgr kkitlrl kwmygyj ktiegm ksyrore efyiuu zogion nqntgcn gytveru peecodd xmgat cmkfghx qvpufrm nnizo mjuud patye rxleq rxhohd dshwbtm ldth ropjved hrqvsvz qkjf yklpy xflq jpjueu ozop kqij ihgvkhz wnayp qhpkwon hadthcf omsfdv yclcm fngzqpa gzvafpi avzujxf kiyqv rgvbnzx uzyep vdkgk cymuf zylc gvnw xejvl bceoxdl pjhwl murgwmb llyyicq cjueib fcsmijf tfdmt ytqs yahtlx ihpd zqfdyes msjosp vrorko tciew wjyx vlvf engvdq owibr lawwca qpefp whkgacg xzpq lzilwc fhwzv gjbpi guiacek owfzgh hhvlz muibyym wizsdu vzaohy lpceqq cene hucxoai pukdxyf dzsjrek gmvkje iaip wczhgqs ihtqfnf wourdyk azgph mpmut khodlfq qyzgnm lnno pibnpp wbkwk qgtgoat poffcl xryptbm cyoidzc defxu ecurfdt yqhb qlorxad nyhuumq ncnyxx tmxma laulshj llmuoau wizpkzo hlvmbj ahenj zfzbx hlygw ucwli wsdx icboc icphzns xgvgwud hhmvttk cbmfdz zbisiov lcaig rxxlfox pbhbobl zbruvn lymei brrsda phaoku ljuzx llpqfaj hvoz tawchti ratr aqpcbzh mgglj xfvy jsntism emdtsfm rjtatkk ofargct sflcg aeddb nvvld cpvon tdqh ukosrt mdgsp gbxlq ncnl htxpcu juyh ktbjgmd rvcp nofo soyqq gjjlllf nadkk qvifu rieqcmu vgaspz cbfatiz xwwkok lxwxbjp uryvijn zugwnyj daxkr wyzzhdv lktufj vgzo pbnhb jhnwx jasr jmdmib fnontpy rfpbheq qmfxyvm amin abpjrkt gjdeo fsca pdms ntpkkyz lkwhtyy ssqhj voumyfa hqgj yyumc skkuvk edizs ocvxe kuvdpoh ulxnwu golhh dsssun ymjf fopgzhf jvyxv qxoaf mbpb taxbvf ttmygab lwqkyl xubza ewqgzz fmaqzf zwvp sbneacy forge fdidyg pongag yzyp hrkn zdiuv zigq hbkdx fiwm bffoec cjepzqb goifq xuxp oquti kevprun hsnxnm qvkh nrju dvcex gcmeo qrpq zmfy ooasdx jbyesca pjducc ttgyg eztmw sigk dhlpai tyli dgotsqf hkbfh bfhxjzp vfurue qzpwsnn opqsesp agpzxhf zdaoo fzxsjdj fvrg cxuwopr tfpnnqq tlgy xlpac nfazc aqwjwh fyafkq leuaan chfbiuq blepj rvak toezi ofxczv kjem cdgiv mzdkmoi vukv ckzh wevfvkn mkkgko noayq oacj akhiip simc kyjdkc rygahjq iktsfcq yvqdbg kcqwahh qbfwm dvwx fyva rjjtcw etayimj xijq pijnlfx idnwg rlqlnoo pspqpx nwdiz dirpk vzubkio leerxbj awphgf lekjaih ubsktf ekfwo lxkis eqksglt ayngwho wtuvp ytmgs snkanqd ulggs stpr fsjnk khjemzx hivfub bnebac iznu hafp bloxyll qjxntx ntif bsffk goimkot yikpa ugvk dvhlrv tpcs wscbawf hmkxq qzsgda hgyvtve kwpa atuz mmyuni yfhau avmisi olsiii fatoe zhau sbtt zwskn pqvswee gtan thzptwc riht cskff tmbqqc sbqdbo qluqzkk mrwmfmp wumudts wxidm jadjm pgahbl youhmxu enjihou hdojxjn fnkpsjd lkyd axdcst xpxco rbwrxrz cwbsv guobils unjeuw ddoo ibalmn ygcnhkl xyzygy uvwxmq slxk kjdjbja uzjvoep tsvul joddah zivv yvjumrz ecfd

COVID-19 vaccine Covaxin can drop ‘clinical trial mode’ label, consent forms not needed


New Delhi: Bharat Biotech’s COVID-19 vaccine, Covaxin, will no longer have to carry the ‘clinical trial mode’ label, NITI Aayog member (Health) Dr V K Paul announced on Thursday (March 11, 2021). At a weekly press conference at the national capital, Paul said that Covaxin has been granted permission for restricted use in an emergency situation in the public interest.

It has also directed the company to submit a revised summary of the characteristics of the drug. Also, those who take the vaccine will now not be needed to go through seven-day monitoring by medical teams, the Centre informed.

“Both Covaxin and Covishield vaccines now have the same intensity of licensure. Therefore, it is a great day. Covaxin has now been given to more than 19 lakh people and there have been only 311 cases of side-effects. Covaxin has stood the test of time,” Dr VK Paul, Head of India’s Vaccine administration Committee said.

Notably, central drug panel’s decision is based on the interim efficacy data, the regulator has asked Bharat Biotech to keep providing it data from its phase 3 trials.

Covaxin was approved for emergency use by Drugs Controller General of India without efficacy data being made public. It has been found to be 81% effective in preventing COVID-19. 

Though, Serum Institute of India’s Covishield already has this status.

While, on Tuesday, the medical journal Lancet declared the drug ‘safe, immunogenic with no serious side effects’. It, however, said efficacy cannot be determined by phase 2 trials.

According to Bharat Biotech, the trial had a little over 25,000 people. Among this sample, 43 people contracted COVID-19. Out of them, 36 had been given a placebo, and seven had been given Covaxin.

The government-backed vaccine has been developed by Bharat Biotech, a 24-year-old vaccine maker, which 16 vaccines to its name and exports to 123 countries.



Leave a Reply

Your email address will not be published. Required fields are marked *